Evidence map›Paper›PMID 42093860›Full record

ArticleJCEM case reports2026

TTF-1-positive primary papillary epithelial tumor of the sella with long-term recurrence after multiple resections.

Vivek Jha, Amal Shaharyar, Vaishali Kaur, Debajyoti Chatterjee, Paramjeet Singh, Pinaki Dutta

Abstract readCase Reports
In one paragraph

Article in JCEM case reports, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors.

Vivek JhaDepartment of Endocrinology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India.ORCID https://orcid.org/0000-0001-7247-5492
Amal ShaharyarDepartment of Endocrinology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India.
Vaishali KaurDepartment of Endocrinology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India.
Debajyoti ChatterjeeDepartment of Histopathology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India.
Paramjeet SinghDepartment of Radiodiagnosis, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India.
Pinaki DuttaDepartment of Endocrinology, Postgraduate Institute of Medical Education and Research (PGIMER), Chandigarh 160012, India.ORCID https://orcid.org/0000-0001-5415-1611

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Primary papillary epithelial tumor of the sella is an extremely rare thyroid transcription factor-1 (TTF-1) positive tumor arising from the posterior pituitary and infundibular area and is often mistaken for a nonfunctioning pituitary adenoma. We report a young woman with a recurrent sellar-suprasellar mass over nearly a decade despite multiple transsphenoidal surgeries. The tumor showed progressive enlargement without hormone hypersecretion. Histopathology revealed a papillary epithelial neoplasm composed of bland cuboidal-to-columnar cells with apical snouting and inflammatory fibrovascular cores. Immunohistochemistry showed strong pancytokeratin, cytokeratin 7, and diffuse nuclear TTF-1 positivity, with negative pituitary hormone and transcription factor markers, confirming the diagnosis. The proliferation index was low. Complete excision was not feasible due to anatomical constraints, resulting in persistent residual disease. This case highlights the need to reconsider the diagnosis in long-standing recurrent sellar masses and emphasizes the importance of expert pathological assessment and prolonged follow-up in these rare tumors.

Indexed as

pituitary adenoma mimicposterior pituitary tumorprimary papillary epithelial tumor of the sellarecurrent sellar massTTF-1

Identifiers

PMID42093860
PMCPMC13142152

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.